| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | RIOT | United States | $15.26 | $637,162,000.00 | Strong Buy | 13 | N/A |
#2 | XPRO | United States | $14.01 | $1,661,811,000.00 | Buy | 4 | 2013 |
#3 | MARA | United States | $11.46 | $919,173,000.00 | Buy | 14 | N/A |
#4 | CWK | United States | $15.30 | $10,003,900,000.00 | Buy | 8 | 2018 |
#5 | TME | China | $18.21 | $4,455,416,345.00 | Strong Buy | 5 | 2018 |
#6 | BZ | China | $19.91 | $1,125,491,208.00 | Strong Buy | 4 | 2021 |
#7 | INTR | Brazil | $8.37 | $1,056,044,206.00 | Buy | 4 | N/A |
#8 | DX | United States | $13.54 | $230,447,000.00 | Buy | 4 | N/A |
#9 | VIV | Brazil | $12.30 | $10,989,199,704.00 | Buy | 4 | 1998 |
#10 | LENZ | United States | $18.11 | $17,500,000.00 | Strong Buy | 4 | 2021 |
#11 | QURE | Netherlands | $19.48 | $15,751,000.00 | Strong Buy | 12 | 2007 |
#12 | NTST | United States | $17.62 | $186,604,000.00 | Strong Buy | 11 | 2020 |
#13 | GHRS | Ireland | $13.05 | $0.00 | Strong Buy | 9 | 2021 |
#14 | CRBP | United States | $9.69 | $0.00 | Strong Buy | 8 | N/A |
#15 | YEXT | United States | $8.32 | $447,666,000.00 | Strong Buy | 4 | 2017 |
#16 | OPRX | United States | $13.36 | $109,506,000.00 | Buy | 6 | N/A |
#17 | XPEV | China | $18.96 | $9,912,782,208.00 | Buy | 6 | 2020 |
#18 | OTLY | Sweden | $11.58 | $842,996,000.00 | Buy | 5 | 2021 |
#19 | FDMT | United States | $10.86 | $120,000.00 | Strong Buy | 9 | 2020 |
#20 | IMTX | Germany | $9.99 | $99,445,031.00 | Strong Buy | 5 | N/A |
#21 | UUUU | United States | $14.57 | $78,742,000.00 | Strong Buy | 5 | N/A |
#22 | GNLX | United States | $4.33 | $0.00 | Strong Buy | 4 | 2023 |
#23 | KURA | United States | $10.22 | $104,029,000.00 | Buy | 11 | N/A |
#24 | AMPX | United States | $10.87 | $58,408,000.00 | Strong Buy | 7 | N/A |
#25 | RUN | United States | $17.95 | $2,316,656,000.00 | Buy | 18 | 2015 |
#26 | ONEW | United States | $11.55 | $1,872,334,000.00 | Buy | 6 | 2020 |
#27 | SMWB | Israel | $7.48 | $275,429,000.00 | Strong Buy | 8 | 2021 |
#28 | WULF | United States | $14.27 | $167,604,000.00 | Strong Buy | 12 | 1995 |
#29 | DOMO | United States | $9.02 | $318,002,000.00 | Buy | 8 | 2018 |
#30 | LFMD | United States | $3.42 | $250,091,814.00 | Strong Buy | 9 | N/A |
#31 | SGMT | United States | $6.25 | $0.00 | Strong Buy | 7 | 2023 |
#32 | XGN | United States | $7.11 | $63,599,000.00 | Strong Buy | 6 | 2019 |
#33 | SOUN | United States | $11.64 | $148,404,000.00 | Buy | 8 | N/A |
#34 | WBX | Spain | $3.03 | $174,593,453.00 | Buy | 4 | N/A |
#35 | ORIC | United States | $9.39 | $0.00 | Strong Buy | 12 | 2020 |
#36 | CRVS | United States | $8.39 | $0.00 | Strong Buy | 4 | 2016 |
#37 | VTYX | United States | $8.21 | $0.00 | Strong Buy | 5 | 2021 |
#38 | BTDR | Singapore | $10.65 | $464,436,000.00 | Strong Buy | 10 | N/A |
#39 | METC | United States | $15.59 | $579,503,000.00 | Buy | 8 | 2017 |
#40 | UAMY | United States | $5.58 | $31,857,819.00 | Strong Buy | 5 | N/A |
#41 | CVRX | United States | $8.44 | $55,969,000.00 | Buy | 7 | 2021 |
#42 | PHAT | United States | $14.53 | $147,190,000.00 | Strong Buy | 6 | 2019 |
#43 | PTRN | United States | $12.63 | $2,293,676,000.00 | Strong Buy | 10 | 2025 |
#44 | OMDA | United States | $15.12 | $232,342,000.00 | Strong Buy | 9 | 2025 |
#45 | AMLX | United States | $13.13 | -$665,000.00 | Strong Buy | 7 | 2022 |
#46 | CIFR | United States | $17.04 | $206,454,000.00 | Strong Buy | 12 | N/A |
#47 | ZLAB | China | $17.76 | $441,629,000.00 | Buy | 6 | 2017 |
#48 | DYN | United States | $19.21 | $0.00 | Strong Buy | 16 | 2020 |
#49 | ADPT | United States | $15.43 | $252,754,000.00 | Strong Buy | 10 | 2019 |
#50 | PHR | United States | $16.25 | $463,205,000.00 | Strong Buy | 17 | 2019 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $20 to Buy (December 14, 2025) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.